The Bcl-2/Bcl-XL Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

James Witham; Melanie R. Valenti; Alexis K. De-Haven-Brandon; Susanne Vidot; Suzanne A. Eccles; Stan B. Kaye; Alan Richardson

doi:10.1158/1078-0432.CCR-07-0362

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Cancer Therapy: Preclinical

The Bcl-2/Bcl-X_L Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

James Witham, Melanie R. Valenti, Alexis K. De-Haven-Brandon, Susanne Vidot, Suzanne A. Eccles, Stan B. Kaye and Alan Richardson

James Witham

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Melanie R. Valenti

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexis K. De-Haven-Brandon

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Susanne Vidot

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Suzanne A. Eccles

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stan B. Kaye

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan Richardson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-07-0362 Published December 2007

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2007 to January 2021

	Abstract	Full-text HTML	PDF
Total	2140	3885	2539

Cited By

Article Information

Volume 13, Issue 23, pp. 7191-7198

DOI

https://doi.org/10.1158/1078-0432.CCR-07-0362

PubMed

18056200

Published By

American Association for Cancer Research

Print ISSN

1078-0432

Online ISSN

1557-3265

History

Accepted August 29, 2007
Received February 12, 2007
Revision received August 2, 2007
Published first December 3, 2007.

American Association for Cancer Research

Author Information

James Witham1,
Melanie R. Valenti2,
Alexis K. De-Haven-Brandon2,
Susanne Vidot1,
Suzanne A. Eccles2,
Stan B. Kaye1 and
Alan Richardson1

Authors' Affiliations:¹Section of Medicine and ²Center for Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom

Requests for reprints:
Alan Richardson, The Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom. Phone: 44-208-722-4025; E-mail: alan.richardson{at}icr.ac.uk.

View Full Text

PreviousNext

December 2007
Volume 13, Issue 23

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Bcl-2/Bcl-XL Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

The Bcl-2/Bcl-X_L Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

James Witham, Melanie R. Valenti, Alexis K. De-Haven-Brandon, Susanne Vidot, Suzanne A. Eccles, Stan B. Kaye and Alan Richardson

Clin Cancer Res December 1 2007 (13) (23) 7191-7198; DOI: 10.1158/1078-0432.CCR-07-0362

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Bcl-2/Bcl-X_L Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

James Witham, Melanie R. Valenti, Alexis K. De-Haven-Brandon, Susanne Vidot, Suzanne A. Eccles, Stan B. Kaye and Alan Richardson

Clin Cancer Res December 1 2007 (13) (23) 7191-7198; DOI: 10.1158/1078-0432.CCR-07-0362

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Articles

Online First
Current Issue
Past Issues
CCR Focus Archive
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About Clinical Cancer Research

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Main menu

User menu

Search

The Bcl-2/Bcl-X_L Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2007 to January 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About Clinical Cancer Research